Hypertrophy Dependent Doubling of L-Cells in Roux-en-Y Gastric Bypass Operated Rats

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Hansen, Carl Frederik ^a,b   Bueter, Marco ^c,d   Theis, Nadine ^d   Lutz, Thomas ^d   Paulsen, Sarah ^a   Dalbøge, Louise S ^a   Vrang, Niels ^a   Jelsing, Jacob ^a  

^a Gubra ^*  (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PEPTIDE YY; PREPROGLUCAGON;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DENSITY; CELL GROWTH; CONTROLLED STUDY; DIET RESTRICTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; L CELL; MALE; NONHUMAN; RAT; ROUX Y ANASTOMOSIS; SMALL INTESTINE; STOMACH BYPASS; STOMACH MUCOSA; TISSUE SPECIFICITY;

ANIMALS; ENTEROENDOCRINE CELLS; GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE 1; HYPERTROPHY; MALE; MUCOUS MEMBRANE; PEPTIDE YY; PROGLUCAGON; RATS; RATS, WISTAR;

RATTUS;

EID: 84878899063     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065696     Document Type: Article

References (63)

1. Wang Y, Beydoun MA, (2007) The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29: 6-28.
2. Grundy SM, (2004) Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 89: 2595-2600.
3. DeMaria EJ, (2007) Bariatric surgery for morbid obesity. N Engl J Med 356: 2176-2183.
4. O'Brien PE, (2010) Bariatric surgery: mechanisms, indications and outcomes. J Gastroenterol Hepatol 25: 1358-1365.
5. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, et al. (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357: 741-752.
6. Eldar S, Heneghan HM, Brethauer SA, Schauer PR, (2011) Bariatric surgery for treatment of obesity. Int J Obes (Lond) 35Suppl 3: S16-21.
7. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, et al. (2003) Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238: 467-484; discussion 484-465.
8. Clements RH, Gonzalez QH, Long CI, Wittert G, Laws HL (2004) Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus. Am Surg 70: 1-4; discussion 4-5.
9. Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, et al. (2004) The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 240: 236-242.
10. Olivan B, Teixeira J, Bose M, Bawa B, Chang T, et al. (2009) Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels. Ann Surg 249: 948-953.
11. le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, et al. (2006) Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 243: 108-114.
12. le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, et al. (2007) Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 246: 780-785.
13. Laferrere B, Heshka S, Wang K, Khan Y, McGinty J, et al. (2007) Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 30: 1709-1716.
14. Laferrere B, Teixeira J, McGinty J, Tran H, Egger JR, et al. (2008) Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 93: 2479-2485.
15. Besterman HS, Adrian TE, Mallinson CN, Christofides ND, Sarson DL, et al. (1982) Gut hormone release after intestinal resection. Gut 23: 854-861.
16. Adrian TE, Savage AP, Bacarese-Hamilton AJ, Wolfe K, Besterman HS, et al. (1986) Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology 90: 379-384.
17. Dowling RH (1982) Small bowel adaptation and its regulation. Scand J Gastroenterol Suppl 74: 53-74.
18. Holst JJ, Sorensen TI, Andersen AN, Stadil F, Andersen B, et al. (1979) Plasma enteroglucagon after jejunoileal bypass with 3: 1 or 1: 3 jejunoileal ratio. Scand J Gastroenterol 14: 205-207.
19. Evrard S, Aprahamian M, Hoeltzel A, Vasilescu M, Marescaux J, et al. (1993) Trophic and enzymatic adaptation of the intestine to biliopancreatic bypass in the rat. Int J Obes Relat Metab Disord 17: 541-547.
20. Stock-Damge C, Aprahamian M, Raul F, Marescaux J, Scopinaro N, (1986) Small-intestinal and colonic changes after biliopancreatic bypass for morbid obesity. Scand J Gastroenterol 21: 1115-1123.
21. Ockander L, Hedenbro JL, Rehfeld JF, Sjolund K, (2003) Jejunoileal bypass changes the duodenal cholecystokinin and somatostatin cell density. Obes Surg 13: 584-590.
22. Mumphrey MB, Patterson LM, Zheng H, Berthoud HR (2012) Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats. Neurogastroenterol Motil.
23. Bueter M, Lowenstein C, Olbers T, Wang M, Cluny NL, et al. (2010) Gastric bypass increases energy expenditure in rats. Gastroenterology 138: 1845-1853.
24. Nadreau E, Baraboi ED, Samson P, Blouin A, Hould FS, et al. (2006) Effects of the biliopancreatic diversion on energy balance in the rat. Int J Obes (Lond) 30: 419-429.
25. Bueter M, Lowenstein C, Ashrafian H, Hillebrand J, Bloom SR, et al. (2010) Vagal sparing surgical technique but not stoma size affects body weight loss in rodent model of gastric bypass. Obes Surg 20: 616-622.
26. le Roux CW, Borg C, Wallis K, Vincent RP, Bueter M, et al. (2010) Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg 252: 50-56.
27. Bueter M, Abegg K, Seyfried F, Lutz TA, le Roux CW (2012) Roux-en-Y Gastric Bypass Operation in Rats. J Vis Exp.
28. Gundersen HJ, Jensen EB, Kieu K, Nielsen J, (1999) The efficiency of systematic sampling in stereology-reconsidered. J Microsc 193: 199-211.
29. Vrang N, Hansen M, Larsen PJ, Tang-Christensen M, (2007) Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nuclei. Brain Res 1149: 118-126.
30. Gundersen HJ, Jensen EB, (1987) The efficiency of systematic sampling in stereology and its prediction. J Microsc 147: 229-263.
31. Sterio DC, (1984) The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134: 127-136.
32. Pakkenberg B, Gundersen HJ, (1988) Total number of neurons and glial cells in human brain nuclei estimated by the disector and the fractionator. J Microsc 150: 1-20.
33. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, et al. (1988) The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96: 857-881.
34. Hansen CF, Vrang N, Sangild PT, Jelsing J, (2013) Novel insight into the distribution of L-cells in the rat intestinal tract. Am J Transl Res 5: 347-358.
35. Eissele R, Goke R, Willemer S, Harthus HP, Vermeer H, et al. (1992) Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest 22: 283-291.
36. Mortensen K, Christensen LL, Holst JJ, Orskov C, (2003) GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul Pept 114: 189-196.
37. Taqi E, Wallace LE, de Heuvel E, Chelikani PK, Zheng H, et al. (2010) The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model. J Pediatr Surg 45: 987-995.
38. Stearns AT, Balakrishnan A, Tavakkolizadeh A, (2009) Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport. Am J Physiol Gastrointest Liver Physiol 297: G950-957.
39. Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG, (2007) Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels. Obes Surg 17: 1193-1198.
40. Strader AD, (2006) Ileal transposition provides insight into the effectiveness of gastric bypass surgery. Physiol Behav 88: 277-282.
41. Dudrick SJ, Daly JM, Castro G, Akhtar M, (1977) Gastrointestinal adaptation following small bowel bypass for obesity. Ann Surg 185: 642-648.
42. Solhaug JH, (1976) Morphometric studies of the small intestine following jejuno-ileal shunt operation. Scand J Gastroenterol 11: 155-160.
43. Solhaug JH, Tvete S, (1978) Adaptative changes in the small intestine following bypass operation for obesity. A radioglocal and histological study. Scand J Gastroenterol 13: 401-408.
44. Jorgensen NB, Jacobsen SH, Dirksen C, Bojsen-Moller KN, Naver L, et al. (2012) Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance. Am J Physiol Endocrinol Metab 303: E122-131.
45. Holst JJ, (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87: 1409-1439.
46. de Wit NJ, Bosch-Vermeulen H, de Groot PJ, Hooiveld GJ, Bromhaar MM, et al. (2008) The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL/6J mice. BMC Med Genomics 1: 14.
47. Bertoni S, Gabella G, (2001) Hypertrophy of mucosa and serosa in the obstructed intestine of rats. J Anat 199: 725-734.
48. Dou Y, Lu X, Zhao J, Gregersen H, (2002) Morphometric and biomechanical remodelling in the intestine after small bowel resection in the rat. Neurogastroenterol Motil 14: 43-53.
49. Dirksen C, Jorgensen NB, Bojsen-Moller KN, Jacobsen SH, Hansen DL, et al. (2012) Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia 55: 1890-1901.
50. Morinigo R, Moize V, Musri M, Lacy AM, Navarro S, et al. (2006) Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 91: 1735-1740.
51. Korner J, Inabnet W, Febres G, Conwell IM, McMahon DJ, et al. (2009) Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) 33: 786-795.
52. Bueter M, Miras AD, Chichger H, Fenske W, Ghatei MA, et al. (2011) Alterations of sucrose preference after Roux-en-Y gastric bypass. Physiol Behav 104: 709-721.
53. Katsuma S, Hirasawa A, Tsujimoto G, (2005) Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 329: 386-390.
54. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, et al. (2005) Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 11: 90-94.
55. Adrian TE, Gariballa S, Parekh KA, Thomas SA, Saadi H, et al. (2012) Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers. Diabetologia 55: 2343-2347.
56. Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, et al. (2009) TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 10: 167-177.
57. Drucker DJ, Erlich P, Asa SL, Brubaker PL, (1996) Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A 93: 7911-7916.
58. Ghatei MA, Goodlad RA, Taheri S, Mandir N, Brynes AE, et al. (2001) Proglucagon-derived peptides in intestinal epithelial proliferation: glucagon-like peptide-2 is a major mediator of intestinal epithelial proliferation in rats. Dig Dis Sci 46: 1255-1263.
59. Orskov C, Holst JJ, Knuhtsen S, Baldissera FG, Poulsen SS, et al. (1986) Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology 119: 1467-1475.
60. Furet JP, Kong LC, Tap J, Poitou C, Basdevant A, et al. (2010) Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 59: 3049-3057.
61. Schonhoff SE, Giel-Moloney M, Leiter AB, (2004) Minireview: Development and differentiation of gut endocrine cells. Endocrinology 145: 2639-2644.
62. Field BC, Chaudhri OB, Bloom SR, (2010) Bowels control brain: gut hormones and obesity. Nat Rev Endocrinol 6: 444-453.
63. Suzuki K, Simpson KA, Minnion JS, Shillito JC, Bloom SR, (2010) The role of gut hormones and the hypothalamus in appetite regulation. Endocr J 57: 359-372.